A milestone for imaging in MASH diagnosis, treatment and monitoring
AuntMinnie
JUNE 14, 2024
For those unfamiliar with steatotic liver disease, this is important because Rezdiffra is the first approved treatment for MASH, which if left untreated can progress to cirrhosis, require liver transplantation, and potentially cause death. Rajarshi Banerjee, MD, PhD.
Let's personalize your content